Roche Holding Ltd ADR

AI Summary

Roche develops and sells prescription medicines for serious diseases—primarily cancer, autoimmune conditions, neurological disorders, and infectious diseases—while also manufacturing diagnostic instruments and laboratory tests that help doctors detect illnesses early [Yahoo Finance]. The company operates two main divisions: pharmaceuticals (drugs) and diagnostics (medical tests and equipment), serving hospitals, clinics, and laboratories across six continents.

Roche Holding is a Swiss pharmaceutical and diagnostics giant with over 103,000 employees, generating $63.4B in annual revenue from medicines treating cancer, autoimmune diseases, and infectious conditions, plus diagnostic tests for diseases like COVID-19 and hepatitis [Yahoo Finance]. The company recently won FDA approval to expand its blockbuster cancer drug Tecentriq into bladder cancer and is advancing a promising experimental breast cancer treatment called giredestrant [Yahoo Finance]. Financially, Roche stands on rock-solid footing with a health score of 8.9/10, strong free cash flow of $13.1B, and minimal net debt at just 0.6x EBITDA [Yahoo Finance].

Roche is financially robust with excellent profitability, minimal debt, and very strong cash generation.

Recent News

• BAYRY or RHHBY: Which Is the Better Value Stock Right Now?

  Zacks· 2026-05-20

• Idiopathic Pulmonary Fibrosis Market Dynamics, Opportunity Analysis and Forecast Report 2026-2035: Therapeutic Landscape is Anchored by Two Key Products - Esbriet (Pirfenidone), and Ofev

  Yahoo Finance· 2026-05-19

• Roche to present new data at ASCO 2026, reinforcing giredestrant's potential to transform the treatment paradigm in early breast cancer

  Yahoo Finance· 2026-05-19

• Polymyositis Market Research Report 2026-2036: Competitive Landscape is Dominated by Major Players Such As Teva Pharmaceuticals, Gilead Sciences, Roche, AbbVie, and Pfizer

  Yahoo Finance· 2026-05-19

• Roche's Tecentriq Wins FDA Nod for Label Expansion in Bladder Cancer

  Yahoo Finance· 2026-05-18

• Middle East and Africa Wearable Injectors Market Trends and Forecast Report 2026-2035 Featuring Amgen, BD, Biocon, Gerresheimer, Insulet, J&J, Medtronic, Roche, West Pharmaceutical, Ypsomed

  Yahoo Finance· 2026-05-18